Injective, the blockchain platform focused on decentralized finance, made a series of announcements at its summit in Washington, D.C., on Tuesday. The company said its native token, INJ, is now available for trading on Robinhood, the retail brokerage app. Separately, Injective has filed with the U.S. Securities and Exchange Commission to register as a transfer agent.
Robinhood listing and what it means
The listing on Robinhood gives millions of retail users direct access to INJ. Robinhood has been expanding its crypto offerings beyond Bitcoin and Ethereum, and Injective becomes the latest addition. The move could boost liquidity and visibility for the token, which is used for staking, governance, and paying fees on the Injective network.
SEC filing for transfer agent status
Injective filed for registration as a transfer agent with the SEC. Transfer agents maintain records of who owns a company's securities and handle the transfer of ownership. The filing suggests Injective is positioning itself to comply with traditional financial regulations, even as it operates a decentralized platform. The SEC has not yet approved or denied the application.
AI SDK and Linux Foundation membership
Injective also launched an artificial intelligence software development kit, or AI SDK. The toolkit is designed to let developers build AI-powered applications on top of the Injective blockchain. The company did not provide details on specific use cases or partners.
Injective became a member of the Linux Foundation, the nonprofit that hosts many open-source projects. The membership gives Injective a seat at the table in shaping standards for blockchain and other technologies.
The announcements came at the Injective Summit, an event the company hosted in Washington, D.C. The location underscores Injective's push to engage with policymakers and regulators.
No timeline was given for the SEC's decision on the transfer agent registration. The company has not said whether the AI SDK is available now or will be released later.
